Skip to main content
Erschienen in: Diabetology International 1/2022

07.09.2021 | Original Article

Explaining the obesity paradox in healthcare utilization among people with type 2 diabetes

verfasst von: Virender Kumar, William Encinosa

Erschienen in: Diabetology International | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Several studies of diabetes suggest an obesity paradox: persons without diabetes have an increased risk of death due to obesity, whereas obesity decreases the risk of death for people with diabetes. A recent study finds the same obesity paradox with the number of healthcare visits. Whether empirical biases and confounding lead to this paradox is yet to be determined.

Objective

To examine changes in the relationship between BMI and number of visits in diabetic vs nondiabetic populations, controlling for confounding risk factors.

Methods

Using adults in the nationally representative Medical Expenditure Panel Survey (MEPS) from 2008 to 2016, N = 210,317, we examine the proposed relationship using six measures of healthcare visits with zero-inflated negative binomial regressions controlling for age, gender, race/ethnicity, income, education, region, health insurance, chronic conditions, and smoking. We excluded persons with type 1 diabetes and gestational diabetes.

Results

We find an obesity paradox among people with diabetes for three measures. That is, relative to people without diabetes, normal weight people with diabetes have more emergency room visits, inpatient, and office-based physician visits than do the obese with diabetes. However, we do not find an obesity paradox in any of the six measures once we exclude smokers and persons ever diagnosed with cancer or cardiovascular disease.

Conclusion

The obesity paradox does not exist at the utilization level and is due to the presence of statistical biases such as confounding and reverse causation. Physicians should continue to focus on efforts to prevent obesity in patients with diabetes.
Literatur
1.
Zurück zum Zitat Adams KF, Schatzkin A, Harris TB, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF. Overweight, obesity and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355:763–78.CrossRef Adams KF, Schatzkin A, Harris TB, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF. Overweight, obesity and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355:763–78.CrossRef
2.
Zurück zum Zitat Mulnier JE, Seaam JE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA. Mortality in people with type 2 diabetes in the UK. Diabet Med. 2006;23(5):516–21.CrossRef Mulnier JE, Seaam JE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA. Mortality in people with type 2 diabetes in the UK. Diabet Med. 2006;23(5):516–21.CrossRef
3.
Zurück zum Zitat Eeggolofsson K, Cedeholm J, Nilsson PM, Zethelius B, Nunez L, Gudbjornsdottir S, Eliasson B. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia. 2009;52:66–73. Eeggolofsson K, Cedeholm J, Nilsson PM, Zethelius B, Nunez L, Gudbjornsdottir S, Eliasson B. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia. 2009;52:66–73.
4.
Zurück zum Zitat Berrington De Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, Maclnnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Mede. 2010;363:2211–9.CrossRef Berrington De Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, Maclnnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Mede. 2010;363:2211–9.CrossRef
5.
Zurück zum Zitat Zheng W, Mclerran DF, Rolland B, Zhang X, Inoue M, Matsuo K, He J, Gupta PC, Ramadas K, Tsugane S, Irie F,Akiko TamaKoshi, , et al. N Engl J Med. 2011;364:719–29.CrossRef Zheng W, Mclerran DF, Rolland B, Zhang X, Inoue M, Matsuo K, He J, Gupta PC, Ramadas K, Tsugane S, Irie F,Akiko TamaKoshi, , et al. N Engl J Med. 2011;364:719–29.CrossRef
6.
Zurück zum Zitat Calle EE, Thun MJ, Petrelli JM, Rodriguez C. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341(15):1097–105.CrossRef Calle EE, Thun MJ, Petrelli JM, Rodriguez C. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341(15):1097–105.CrossRef
7.
Zurück zum Zitat Diehr P, Bild DE, Harris TB, Duxbury A, Siscovick D, Rossi M. Body mass index and mortality in nonsmoking older adults: the cardiovascular health study. Am J Public Health. 1998;88(4):623–9.CrossRef Diehr P, Bild DE, Harris TB, Duxbury A, Siscovick D, Rossi M. Body mass index and mortality in nonsmoking older adults: the cardiovascular health study. Am J Public Health. 1998;88(4):623–9.CrossRef
8.
Zurück zum Zitat Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L. NEDCOM, the Netherland epidemiology and demography compression of morbidity research group. Ann Int Med. 2003;138(1):24–32.CrossRef Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L. NEDCOM, the Netherland epidemiology and demography compression of morbidity research group. Ann Int Med. 2003;138(1):24–32.CrossRef
9.
Zurück zum Zitat Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):305–13.CrossRef Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):305–13.CrossRef
10.
Zurück zum Zitat Dunlap SH, Sueta CA, Tomasko L, Adams KF Jr. Association of body mass, gender, and race with heart failure primarily due to hypertension. J Am Coll Cardiol. 1999;34(5):1602–8.CrossRef Dunlap SH, Sueta CA, Tomasko L, Adams KF Jr. Association of body mass, gender, and race with heart failure primarily due to hypertension. J Am Coll Cardiol. 1999;34(5):1602–8.CrossRef
11.
Zurück zum Zitat Katzmarzyk PT, Janssen I, Ardern CI. Physical inactivity, excess adiposity and premature mortality. Obes Rev. 2003;4(4):257–90.CrossRef Katzmarzyk PT, Janssen I, Ardern CI. Physical inactivity, excess adiposity and premature mortality. Obes Rev. 2003;4(4):257–90.CrossRef
12.
Zurück zum Zitat Costanzo P, Cleland JGF, Pellicori P, Clark AL, Hepburn D, Kilpatrick ES, Perrone-Filardi P, Zhang J, Atkin SL. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis. Ann Intern Med. 2015;162:610–8.CrossRef Costanzo P, Cleland JGF, Pellicori P, Clark AL, Hepburn D, Kilpatrick ES, Perrone-Filardi P, Zhang J, Atkin SL. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis. Ann Intern Med. 2015;162:610–8.CrossRef
13.
Zurück zum Zitat Carnethon MR, De Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, Golden SH, Liu K, Mukamal KJ, Campbell-Jenkins B, Dyer AR. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308(6):581–90.CrossRef Carnethon MR, De Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, Golden SH, Liu K, Mukamal KJ, Campbell-Jenkins B, Dyer AR. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308(6):581–90.CrossRef
14.
Zurück zum Zitat Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine. Heart. 2009;95(6):454–60.CrossRef Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine. Heart. 2009;95(6):454–60.CrossRef
15.
Zurück zum Zitat Lajous M, Bijon A, Fagherazzi G, Boutron-Ruault MC, Balkau B, Clavel-Chapelon F, Hernan MA. Epidemiology. 2014;25(1):10–4.CrossRef Lajous M, Bijon A, Fagherazzi G, Boutron-Ruault MC, Balkau B, Clavel-Chapelon F, Hernan MA. Epidemiology. 2014;25(1):10–4.CrossRef
16.
Zurück zum Zitat Logue J, Walker JJ, Leese G, Lindsay R, McKnight J, Morris A, Philip S, Wild S, Sattar N. Scottish diabetes research network epidemiology group. Diabetes Care. 2013;36(4):887–93.CrossRef Logue J, Walker JJ, Leese G, Lindsay R, McKnight J, Morris A, Philip S, Wild S, Sattar N. Scottish diabetes research network epidemiology group. Diabetes Care. 2013;36(4):887–93.CrossRef
17.
Zurück zum Zitat Thomas G, Khunti K, Curcin V, Molokhia M, Millett C, Majeed A, Paul S. Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease. Diabetes Obes Metab. 2014;16:317–25.CrossRef Thomas G, Khunti K, Curcin V, Molokhia M, Millett C, Majeed A, Paul S. Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease. Diabetes Obes Metab. 2014;16:317–25.CrossRef
18.
Zurück zum Zitat Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Li W, Johnson J, Heymsfield SB, Cefalu WT, Ryan DH, Hu G. Body mass index and the risk of all-cause mortality among patients with type 2 diabetes mellitus. Circulation. 2014;130(24):2143–51.CrossRef Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Li W, Johnson J, Heymsfield SB, Cefalu WT, Ryan DH, Hu G. Body mass index and the risk of all-cause mortality among patients with type 2 diabetes mellitus. Circulation. 2014;130(24):2143–51.CrossRef
19.
Zurück zum Zitat McEwen LN, Karter AJ, Waitzfelder BE, Crosson JC, Marrero DG, Manqione CM, Herman WH. Predictors of mortality over 8 years in type 2 diabetic patients: translating research into action for diabetes. Diabetes Care. 2012;35:1301–9.CrossRef McEwen LN, Karter AJ, Waitzfelder BE, Crosson JC, Marrero DG, Manqione CM, Herman WH. Predictors of mortality over 8 years in type 2 diabetic patients: translating research into action for diabetes. Diabetes Care. 2012;35:1301–9.CrossRef
20.
Zurück zum Zitat Hainer V, Aldhoon-Hainerova I. Obesity paradox does exist. Diabetes Care. 2013;36(suppl 2):S276–81.CrossRef Hainer V, Aldhoon-Hainerova I. Obesity paradox does exist. Diabetes Care. 2013;36(suppl 2):S276–81.CrossRef
21.
Zurück zum Zitat Standl E, Erbach M, Schnell O. Defending the con side: obesity paradox does not exist. Diabetes Care. 2013;36(suppl 2):S282–6.CrossRef Standl E, Erbach M, Schnell O. Defending the con side: obesity paradox does not exist. Diabetes Care. 2013;36(suppl 2):S282–6.CrossRef
22.
Zurück zum Zitat Hauner H, et al. Obesity and diabetes. In: Holt RIG, Cockram CS, Flyvbjerg A, et al., editors. Textbook of diabetes. 4th ed. Oxford: Wiley-Blackwell; 2010. Hauner H, et al. Obesity and diabetes. In: Holt RIG, Cockram CS, Flyvbjerg A, et al., editors. Textbook of diabetes. 4th ed. Oxford: Wiley-Blackwell; 2010.
23.
Zurück zum Zitat Preston SH, Stokes A. Obesity paradox conditioning on disease enhances biases in estimating the mortality risks of obesity. Epidemiology. 2014;25(3):454–61.CrossRef Preston SH, Stokes A. Obesity paradox conditioning on disease enhances biases in estimating the mortality risks of obesity. Epidemiology. 2014;25(3):454–61.CrossRef
24.
Zurück zum Zitat Manson JE, Stampfer MJ, Hennekens CH, Willett WC. Body weight and longevity: a reassessment. JAMA. 1987;257:353–8.CrossRef Manson JE, Stampfer MJ, Hennekens CH, Willett WC. Body weight and longevity: a reassessment. JAMA. 1987;257:353–8.CrossRef
25.
Zurück zum Zitat Tobias DK, Pan A, Jackson CL, O’Reilly EJ, Ding EL, Willett WC, Manson JE, Hu FB. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370:233–44.CrossRef Tobias DK, Pan A, Jackson CL, O’Reilly EJ, Ding EL, Willett WC, Manson JE, Hu FB. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370:233–44.CrossRef
26.
Zurück zum Zitat Habbu A, Lakkis NM, Dokainish H. The obesity paradox: fact or fiction? Am J Cardiol. 2006;98:944–8.CrossRef Habbu A, Lakkis NM, Dokainish H. The obesity paradox: fact or fiction? Am J Cardiol. 2006;98:944–8.CrossRef
27.
Zurück zum Zitat Braun TP, Zhu X, Szumowski M, Scott GD, Grossberg AJ, Levasseur PR, Graham K, Khan S, Damaraju S, Colmers WF, Baracos VE, Marks DL. Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. J Exp Med. 2011;208:2449–63.CrossRef Braun TP, Zhu X, Szumowski M, Scott GD, Grossberg AJ, Levasseur PR, Graham K, Khan S, Damaraju S, Colmers WF, Baracos VE, Marks DL. Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. J Exp Med. 2011;208:2449–63.CrossRef
28.
Zurück zum Zitat Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006;83:735–43.CrossRef Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006;83:735–43.CrossRef
29.
Zurück zum Zitat Jerant A, Bertakis KD, Franks P. Body mass index and health care Utilization in diabetic and nondiabetic individuals. Med Care. 2015;53(5):409–16.CrossRef Jerant A, Bertakis KD, Franks P. Body mass index and health care Utilization in diabetic and nondiabetic individuals. Med Care. 2015;53(5):409–16.CrossRef
30.
Zurück zum Zitat Powell-Wiley TM, Poirier P, Burke LE, Després J, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, St-Onge M. and On behalf of the American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143(21):e984–1010. https://doi.org/10.1161/CIR.0000000000000973. Powell-Wiley TM, Poirier P, Burke LE, Després J, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, St-Onge M. and On behalf of the American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143(21):e984–1010. https://​doi.​org/​10.​1161/​CIR.​0000000000000973​.
31.
Zurück zum Zitat Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D’Agostino RB Sr, Wilson PW, Savage PJ. Trends in cardiovascular complications of diabetes. JAMA. 2004;292:2495–9.CrossRef Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D’Agostino RB Sr, Wilson PW, Savage PJ. Trends in cardiovascular complications of diabetes. JAMA. 2004;292:2495–9.CrossRef
32.
Zurück zum Zitat Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, Bibbins-Domingo K. The impact of the aging population on coronary heart disease in the United States. Am J Med. 2011;124:827-833.e5.CrossRef Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, Bibbins-Domingo K. The impact of the aging population on coronary heart disease in the United States. Am J Med. 2011;124:827-833.e5.CrossRef
34.
Zurück zum Zitat O’Connor PJ, Rush WA, Pronk NP, Cherney LM. Identifying diabetes mellitus or heart disease among health maintenance organization members: sensitivity, specificity, predictive value, and cost of survey and database methods. Am J Manag Care. 1998;4(3):335–42.PubMed O’Connor PJ, Rush WA, Pronk NP, Cherney LM. Identifying diabetes mellitus or heart disease among health maintenance organization members: sensitivity, specificity, predictive value, and cost of survey and database methods. Am J Manag Care. 1998;4(3):335–42.PubMed
36.
Zurück zum Zitat Coutinho T, Goel K, Corrêa de Sá D, Kragelund C, Kanaya AM, Zeller M, et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol. (2011) 57:1877–86. https://doi.org/10.1016/j.jacc.2010.11.058. Coutinho T, Goel K, Corrêa de Sá D, Kragelund C, Kanaya AM, Zeller M, et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol. (2011) 57:1877–86. https://​doi.​org/​10.​1016/​j.​jacc.​2010.​11.​058.​
Metadaten
Titel
Explaining the obesity paradox in healthcare utilization among people with type 2 diabetes
verfasst von
Virender Kumar
William Encinosa
Publikationsdatum
07.09.2021
Verlag
Springer Singapore
Erschienen in
Diabetology International / Ausgabe 1/2022
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-021-00530-5

Weitere Artikel der Ausgabe 1/2022

Diabetology International 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.